Bluewater Bio Secures £4 Million Investment from Ecofin & Aqua Resources

Bluewater Bio (UK) is pleased to announce that it has successfully raised £4 million from new and existing investors. Ecofin Water & Power Opportunities Plc (“Ecofin”), the renowned utilities, energy and environmental investment firm, has invested £2 million in Bluewater Bio by way of £2 million subscription for secured loan notes, due in 2012, together with warrants to subscribe for up to 5,714,285 ordinary shares at 17.5p each in the capital of Bluewater Bio. In addition the Company has secured a further £2 million on the same terms as Ecofin, from existing investor Aqua Resources Fund Limited (“Aqua”), the authorised closed-ended investment scheme managed by FourWinds Capital Management (“FourWinds”).

These high profile investments follow strong progress from Bluewater Bio in both Bahrain and South Africa, where the Company’s proprietary wastewater treatment technology is being recognised for its clear environmental and financial benefits.

Having conclusively proven its HYBACs technology across the world, this latest round of high-profile financial backing comes at a time when Bluewater Bio is shifting its strategy towards acquisitions. In this new phase of its evolution, the Company is examining compatible technologies and new markets that could boost its already burgeoning global presence. Contract wins in the Middle East and South Africa have demonstrated the appeal of HYBACS in areas of the world where the problem of water scarcity is becoming ever more acute. As well as enabling opportunistic acquisitions, the funds will also further accelerate the international roll out of Bluewater Bio’s proprietary technology, working with select strategic partners, utilities and governmental bodies.